Background: Carbapenem-resistant Enterobacteriaceae (CRE) represent a global public health threat. Emergence of carbapenems-resistant organisms represents a serious challenge for antimicrobial therapy. Among the widely recognized types of Carbapenemases, New Delhi β-lactamase (NDM) and Klebsiella pneumoniae carbapenemase (KPC) are the most important enzymes. Objective: The aim of this research is to determine the genotypic prevelance of NDM and KPC genes among Gram negative organisms with high-level Carbapenem resistance from respiratory tract specimens at Government Medical College Kottayam using RT-PCR . Method: A total of 1216 respiratory tract specimens including sputum, bronchoalveolar lavage and tracheal aspirate were collected during June 2017 to November 2017. The susceptibility of all isolates to Meropenem was selected by disc diffusion method according to Clinical Laboratory Standards Institute guidelines. Isolates with intermediate susceptibility to Meropenem and Meropenem resistant isolates were further selected for genotyping. The presence of genes coding for Carbapenemases such as bla NDM-1 and bla KPC was detected by polymerase chain reaction. Results: Out of 290 isolates, 40 isolates are resistant to Carbapenems phenotypically. 14% (31/220) were Klebsiella pneumonia and 12.8% (9/70) were Escherichia coli. Genotypic study shows 3 out of the 40 isolates possessed NDM gene and all three were Klebsiella pneumoniae. No KPC gene was located in all 40 isolates. Escherichia coli did not posess both NDM or KPC genes. Conclusion: Carbapenem resistance is due to injudicious use of higher antibiotics, therefore to prevent this, periodic surveillance of sputum cultures, antibiotic resistance pattern and regular updates on antibiotic policy guidelines is the best strategy.
Introduction
Antibiotic resistance is a tremendous health problem. This includes the resistance to Carbapenems which was considered as the last resort for Enterobacteriaceae infections 1 . Carbapenems, among the beta-lactams, are the http://jmscr.igmpublication.org/home/ ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i9.94 most effective against Gram-positive and Gramnegative bacteria, their unique molecular structure due to the presence of a Carbapenem together with the beta-lactam ring. This combination confers exceptional stability against most betalactamases (enzymes that inactivate beta-lactams) including Ampicillin and Carbenicillin (AmpC) and the Extended Spectrum beta-lactamases (ESBLs) 2 .
Carbapenemase-producing Enterobacteriaceae (CPE) are well known to cause many serious infections resulting in increasing mortality rate, treatment cost, and prolonged hospitalization. 3 It has developed due to the acquisition of genes encoding Carbapenemases (carbapenem hydrolyzing enzymes). Three classes of carbapenemases (A, B and D) are involved in the Carbapenem resistance (i) class A Klebsiella pneumoniae carbapenemase (KPC) (ii) class B,
Metallo-β-lactamases (MBLs) such as Verona integron
Metallo-beta-lactamase (VIM), Imipenemase Metallo-beta-lactamase (IMP) and New Delhi Metallo-beta-lactamase (NDM) and (iii) class D, Oxacillin hydrolyzing betalactamases (OXA). These bacteria have spread rapidly through mobilisable genetic elements for example, plasmid IncX3, IncA/C2; transposon Tn4401, Tn125 , or class I Integron. 4 In 2017, the World Health Organization published a list of superbugs including CRE. Carbapenemase production and ESBL/AmpC βlactamase production coupled with porin loss or efflux pump were the common ways that Enterobacteriaceae become resistant to carbapenems. New Delhi Metallo-β-lactamase-1 (NDM-1) was found in Asia with the highest frequency; Klebsiella pneumoniae carbapenemase (KPC) was the most popular enzyme causing carbapenem resistance, especially KPC-2 in USA. Among various methods, PCR, real-time PCR, and DNA sequencing are the gold standards for carbapenemase-encoding genes detection. 4 This study attempts to trace NDM and KPC carbapenamases in respiratory tract samples in tertiary care centre at Kottayam in central Kerala, India. The primers were used accordingly, and the genotypes among MDR strains of bacteria of the family Enterobactericeae were determined.
Materials and Methods Isolation of bacterial Isolates
A total of 1216 respiratory tract specimens namely sputum, bronchoalveolar lavage and tracheal aspirate were collected during June 2017 to November 2017. Culture yielded 290 Gram negative isolates which were selected for processing. All isolates were plated on blood agar, MacConkey agar and chocolate agar and identified in accordance with the biochemical standard assay methods.
Antibiotic Susceptibility Testing of Isolates
The susceptibility of all isolates to antibiotics were selected by disc diffusion method according to Clinical Laboratory Standards Institute guidelines. 
Results:
The specimens collected from lower respiratory tract infections include sputum, bronchoalveolar lavage and tracheal aspirate as in Table 1 . The most common specimen was sputum accounting for 76% of specimens followed by bronchoalveolar lavage and tracheal aspirate. 28% of specimens were from Pulmonology unit, 22% from Cardiothoracic unit and 20% from critical care unit-both medical and surgical. The remaining 30% of specimens were from Medicine, Nephrology and Neurosurgery units. 77% of specimens were from males and 23% were from females. Table 3 shows the prevalence of meropenem resistance among 31 isolates of Klebsiella pneumoniae and 9 of E coli of Enterobactericeae. Thus 40 of the total isolates are showing meropenem resistance. Table 4 shows the prevalence of carbapenamases among Gram negative rods as present in Klebsiella pneumoniae and E coli based on the presence of genes coding for carbapenemases such as bla NDM-1 and bla KPC detected by polymerase chain reaction. Of the total 40 multidrug resistant isolates only 3 isolates were positive for carbapenamases which was positive for the presence of the gene NDM. No KPC gene positive isolates were isolated.
Discussion
Carbapenems have been kept as the last antibiotic choice for the treatment of severe infections; however, the development of carbapenem resistance significantly compromises their activities. 1 In this study, out of the 1216 samples from Respiratory tract; 290 isolates (23.8%) were obtained out of which Klebsiella pneumoniae were 220 (82%) and 70 (18%). This is similar to the study by Gunjal et al where 75.86% Klebsiella pneumoniae and 24.13% E coli were isolated from sputum samples. 9 Shilpa K et al showed that among 128 Klebsiella pneumoniae from sputum samples in a tertiary care hospital, 30 (23%) were Klebsiella pneumonia. 10 In another study by Babakani et al 36.3% of Klebsiellae were isolated from sputum samples. 11 In this study 189 Klebsiella pneumoniae (85.9%) and 61 E coli (87.1%) isolates were sensitive to meropenem. This corresponds to the study by Saha et al with 83.33% meropenem sensitivity for E.coli isolated from sputum samples 12 and to that by Sharma et al with 90% carbapenem sensitivity for Klebsiella species and 80% sensitivity for E.coli. 13 Phenotypic screening was done as per CLSI guidelines of 2017, 40 isolates with intermediate susceptibility or resistance to meropenem were obtained out of which Klebsiella pneumoniae were 31 (14%) and E coli 9 (12.8%) .These findings are low as compared to the study by S P Gunjal et al where 36.36% Klebsiella pneumoniae and 85.71% E coli were resistant to meropenem. 9 But it corresponds to the study by Sharma P et al with 10% carbapenem resistance for Klebsiella species and 20% for E.coli 13 and a study by Saha AK et al with 16.7% meropenem resistance for E coli. 12 Among these, more than half were isolated from respiratory specimens (62.9%), including 75 (30.9%) from sputum, 38 (15.6%) from endotracheal aspirate (ETA), and 40 (16.4%) from broncho alveolar lavage fluid and similar findings are also seen in the study by Li Y et al. 14 In this study out of the 31 resistant Klebsiella pneumoniae isolates only 3 bla NDM-1 was detected and bla KPC was absent. bla NDM-1 and bla KPC were both absent among E.coli. In a study by Barwa et al similar findings were noted with five isolates contained bla NDM -1 isolated among Klebsiella pneumoniae with elevated resistance to carbapenems. 1, 15, 16 Arijit Bora et al showed that 8.7% NDM-1 were detected among 219 non-duplicated K pneumoniae isolates in their study. 16 This corresponds to our study in which NDM-1 (9.7%) gene was isolated out of the 31 resistant Klebsiella pneumoniae isolates. However, in this study none of our isolates were positive for bla KPC . Our finding was in agreement with that of Mohan B et al and Nagaraj S et al who also did not find bla KPC in any of their carbapenem resistant isolates. 17, 18 Carbapenem resistance may also be due to diminished permeability of the outer membrane, hyperproduction of ESBLs and AmpC associated with alteration or loss of porins or due to an active efflux pump system.
Conclusion
Carbapenem resistance is due to injudicious and empiric therapy with the higher generation of antibiotics in the hospitals. Therefore, previous usage of antibiotics should be the influential factor for understanding the elements of antimicrobial resistance. Periodic antimicrobial surveillance in case of hospital acquired infections is regularly needed to update the guidelines on proper choice of organism specific as well as empiric antibiotics.
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